A recent clinical study reveals that combining a vitamin D analogue with chemotherapy may significantly improve the effectiveness of pancreatic cancer treatment, opening new avenues in combating this aggressive disease.
Reports indicate that cancer treatment costs can reach hundreds of thousands of dollars, increasing pressure on patients and their families. A brain cancer survivor from the 1990s discusses how the Affordable Care Act impacted these costs.
Triomics has raised <strong>$22 million</strong> in a Series B funding round led by <strong>Battery Ventures</strong> to develop artificial intelligence technologies for cancer treatment. This investment comes at a crucial time as medical institutions seek to improve treatment outcomes using advanced technology.
Despite significant progress in cancer treatments, the disease continues to claim around <strong>12 million</strong> lives annually worldwide. This raises questions about the factors hindering the discovery of definitive solutions to cancer.
Recent studies have reported significant advancements in the treatment of solid tumors, highlighting the development of genetically modified immune cells capable of efficiently targeting cancer while dismantling chemical defenses of tumors. These breakthroughs represent crucial steps toward a radical transformation in how the deadliest types of cancer are confronted.
The UK's National Health Service has announced a new injection for cancer treatment, enabling thousands of patients to significantly reduce their hospital treatment time. The new treatment, known as <strong>Keytruda</strong>, offers an effective alternative to traditional intravenous injections.
A recent laboratory study has revealed the effectiveness of the Ghassoul plant in fighting cancer cells, opening new avenues in treatment. The findings suggest that this plant may play a significant role in developing future therapies.
A recent clinical study revealed promising results for an experimental drug called <strong>setidegrasib</strong>, which has been able to slow the growth of certain types of cancer and reduce tumors in several patients. This drug represents a significant step in modern medicine aimed at tackling challenging oncological treatments.
Scientists from Perm Technical University and the Moscow Research Center have unveiled innovative new molecules based on selenium, tungsten, and palladium compounds that could revolutionize cancer treatment. This breakthrough represents a potential alternative to the currently used gold nanoparticles in certain therapies.
A team of scientists has unveiled a new mechanism related to the JAK1 gene, revealing its transformation from a tumor suppressor to a tumor enhancer. This discovery sheds light on the aggressiveness of certain tumors and opens new avenues for cancer treatment.
A tribunal has revoked the license of a doctor accused of charging up to £15,000 for unproven cancer treatments using garlic oil and Vitamin C. The doctor, known for illegal practices, treated patients in unsanitary conditions.
The American Association for Cancer Research (AACR 2026) conference in Chicago unveiled a groundbreaking AI model named 'Path-IO' that redefines the role of tissue slides in guiding treatment decisions, allowing for more precise medical choices.
Scientists from Novosibirsk University have developed a novel oncolytic virus that features an immune-boosting gene and an additional mutation, making it effective in destroying cancer cells while minimizing damage to healthy cells.
Researchers have uncovered a hidden protein that plays a significant role in the development of skin cancer by hindering the immune system's ability to combat cancer cells. These findings may pave the way for new treatment avenues for this type of cancer.
Recent studies have shown the success of an innovative drug in increasing the average lifespan of patients with advanced pancreatic cancer, surpassing traditional chemotherapy treatments. These findings represent a new ray of hope in the fight against this deadly disease.
Eli Lilly has announced its acquisition of Calyonia Pharmaceuticals in a deal valued at $7 billion. The agreement includes an upfront payment of $3.25 billion, with additional payments contingent on achieving clinical, regulatory, and commercial milestones.
Tianjin University Cancer Hospital has announced remarkable achievements in precision surgery using robotics, successfully performing over <strong>10,000 surgeries</strong>. These developments reflect significant progress in modern treatment technologies.
The Friends of Cancer Patients Association concluded its participation in the 'Regional Oncology Conference' held in Kuwait, discussing the latest developments in cancer treatment. The event saw extensive participation from experts and specialists in the field.
The Malaysian Deputy Health Minister, <strong>Dato Hanifah Hajar Taib</strong>, announced the establishment of the <strong>Sarawak Cancer Center</strong> in 2027, following the completion of the project design. This initiative aims to enhance cancer treatment services in Sarawak and neighboring areas.
Scientists from Abu Dhabi have announced the development of new materials effective in combating cancer, easily detectable through magnetic resonance imaging. This innovation marks a significant step towards improving early diagnosis and effective treatment.
Researchers at New York University Abu Dhabi have developed smart nanoparticles capable of detecting and treating cancer at the same time. This advancement represents a significant step forward in healthcare, reflecting scientific progress in combating incurable diseases.
A team of researchers has unveiled an innovative drug compound that helps slow the spread of colon, rectal, and liver cancer. This groundbreaking discovery could pave the way for more effective cancer treatments.
Researchers at NYU Abu Dhabi have developed smart particles with exceptional capabilities to detect and treat cancerous tumors, paving the way for more precise and safer treatments. This innovative technology represents a significant scientific achievement in cancer therapy.
KHZ Mustafa Hospital in Tasikmalaya, West Java, has announced the opening of comprehensive cancer treatment services to facilitate access for local patients. This development follows years of planning aimed at reducing the need for travel to distant hospitals.
The Russian Ministry of Health has announced the use of a vaccine specifically designed to treat melanoma skin cancer, administered to the first patient, a 60-year-old man. This development is part of Russia's efforts to address cancer treatment challenges.
Researchers at the Massey Comprehensive Cancer Center have developed a new drug aimed at preventing the spread of prostate cancer to the bones, potentially changing treatment approaches for this serious disease affecting millions of men worldwide.
A recent study reveals that <strong>Telmisartan</strong>, a medication for high blood pressure, significantly enhances the effectiveness of the immunotherapy <strong>Olaparib</strong> against cancer, opening new avenues in the fight against tumors.
A recent clinical study at the cancer treatment center in Los Angeles reveals promising outcomes for recurrent prostate cancer using targeted PSMA nuclear therapy. This could revolutionize available treatment options.
Researcher Boris Gladkikh from Volgograd Technical University reveals ongoing efforts to develop new pharmaceutical compounds aimed at inhibiting the defense systems of cancer cells, making them more susceptible to traditional treatments. This innovation comes at a time when cancer cases are on the rise globally.
Researchers have made significant scientific progress in cancer treatment by utilizing CRISPR technology to inject immune cells directly into the body, potentially eliminating the need for traditional chemotherapy. This breakthrough was revealed in a study published on March 18, 2026, in the journal Nature.